Galderma Announces Exclusive Agreement With Sofregen to Develop the Next Generation of Biostimulator Fillers Using Silk-Based Technology

首圖 LAUSANNE, Switzerland & FRAMINGHAM, Mass.–(BUSINESS WIRE)–Galderma, the world』s largest independent dermatology company, and Sofregen Medical, Inc., a medical device company pioneering th…


發佈留言